Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Wijermans

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Annals of Hematology|November 18, 2005
In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studiesBjörn Hackanson, Christian Robbel, Pierre Wijermans, et al.
Journal of Clinical Medicine|August 4, 2015
Clinical Results of Hypomethylating Agents in AML TreatmentMarjan Cruijsen, Michael Lübbert, Pierre Wijermans, et al.
Leukemia Research|September 16, 2005
Treatment of myelodysplastic syndrome with a DNA methyltransferase inhibitor: lack of evidence for induction of chromosomal instabilityPeter S Haas, Pierre Wijermans, Gregor Verhoef, et al.
Leukemia Research|October 12, 2004
Nonclonal neutrophil responses after successful treatment of myelodysplasia with low-dose 5-aza-2'-deoxycytidine (decitabine)Michael Lübbert, Michael Daskalakis, Regina Kunzmann, et al.
Blood|September 28, 2002
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatmentMichael Daskalakis, Tudung T Nguyen, Carvell Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 StudyPierre Wijermans, Martijn Schaafsma, Fabian Termorshuizen, et al.
Prenatal Diagnosis|October 28, 2011
Feasibility of nonselective testing for hemoglobinopathies in early pregnancy in The NetherlandsJudith O Kaufmann, Gönül Demirel-Güngör, Anke Selles, et al.
Haematologica|August 10, 2012
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcomeBarbara Deschler, Gabriele Ihorst, Uwe Platzbecker, et al.
Plos One|July 21, 2017
Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST studySaskia Persoon, Mai J M ChinAPaw, Laurien M Buffart, et al.
Blood|June 15, 2011
Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trialsPeter M Fayers, Antonio Palumbo, Cyrille Hulin, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Annals of Hematology|November 18, 2005
In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studiesBjörn Hackanson, Christian Robbel, Pierre Wijermans, et al.
Journal of Clinical Medicine|August 4, 2015
Clinical Results of Hypomethylating Agents in AML TreatmentMarjan Cruijsen, Michael Lübbert, Pierre Wijermans, et al.
Leukemia Research|September 16, 2005
Treatment of myelodysplastic syndrome with a DNA methyltransferase inhibitor: lack of evidence for induction of chromosomal instabilityPeter S Haas, Pierre Wijermans, Gregor Verhoef, et al.
Leukemia Research|October 12, 2004
Nonclonal neutrophil responses after successful treatment of myelodysplasia with low-dose 5-aza-2'-deoxycytidine (decitabine)Michael Lübbert, Michael Daskalakis, Regina Kunzmann, et al.
Blood|September 28, 2002
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatmentMichael Daskalakis, Tudung T Nguyen, Carvell Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 StudyPierre Wijermans, Martijn Schaafsma, Fabian Termorshuizen, et al.
Prenatal Diagnosis|October 28, 2011
Feasibility of nonselective testing for hemoglobinopathies in early pregnancy in The NetherlandsJudith O Kaufmann, Gönül Demirel-Güngör, Anke Selles, et al.
Haematologica|August 10, 2012
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcomeBarbara Deschler, Gabriele Ihorst, Uwe Platzbecker, et al.
Plos One|July 21, 2017
Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST studySaskia Persoon, Mai J M ChinAPaw, Laurien M Buffart, et al.
Blood|June 15, 2011
Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trialsPeter M Fayers, Antonio Palumbo, Cyrille Hulin, et al.
Pageof 3